Use of yttrium-90 (Y90) glass microspheres (TheraSphere) as neoadjuvant to transplantation/resection in hepatocellular carcinoma: Analyses from the LEGACY study.

Robert J. Lewandowski,Guy E. Johnson,Edward Kim,Ahsun Riaz,Vivian Bishay,Siddharth A. Padia,Riad Salem

Use of yttrium-90 (Y90) glass microspheres (TheraSphere) as neoadjuvant to transplantation/resection in hepatocellular carcinoma: Analyses from the LEGACY study.

2021

Robert J. Lewandowski
Guy E. Johnson
Edward Kim
Ahsun Riaz
Vivian Bishay
Siddharth A. Padia
Riad Salem

300Background: The objective of the LEGACY study was to assess the Objective Response Rate (ORR) and Duration of Response (DoR) following treatment with Yttrium-90 (Y90) glass microspheres in patie...

Keywords:

Resection
Transplantation
Yttrium
objective response
Hepatocellular carcinoma
TheraSphere
Nuclear medicine
Medicine
Glass microsphere

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations